2014 Archived Content
Register for Webinar Only | Register for Webinar and FAST Congress
Symposium Length: 2 hours (incl. Q&A)
Interested in 3-D printing applications in medicine, not just what we are doing today but what we could be doing in the future and how we get there? For example, can we "print" medical devices? Can we "print" permanent implants? Can we "print" drugs (i.e., new molecular entities)? Can we "print" living tissue? What are the technical and regulatory challenges these new technologies pose? Using case studies from a variety of clinical
specialities, all of these and more will be discussed in this interactive webinar. Strategies for using regulation as a competitive advantage will also be
- Understand what is currently being done in biomedical 3-D printing
- Appreciate the technical and regulatory challenges and how to address them
- Be aware of applications and technologies underdevelopment
Who Should Attend:
Geared for both experienced medical professionals as well as those new to the industry, this webinar is designed for those who need a
better understanding of the medical applications of 3-D printing from a clinical, regulatory and manufacturing perspective. Scientists, engineers and
technicians working on device design and development, product and product development managers, business development managers, marketing managers, QA/QC
personnel, regulatory affairs professionals, investment and acquisition specialists and field service engineers will all benefit from this webinar.
Michael Drues, Ph.D.
About Dr. Drues:
Michael Drues, Ph.D., is President of Vascular Sciences (www.vascularsci.com), an education, training, & consulting company offering a
broad range of services to medical device, pharmaceutical & biotechnology companies including stimulating & innovative educational programming, brainstorming sessions, prototype design, product development, benchtop & animal testing, regulatory strategy, intelligence & clinical trial design, FDA
presentation preparation & defense, reimbursement, clinical acceptance, business development & technology assessment.
Dr. Drues received his BS, MS, and Ph.D. degrees in Biomedical Engineering from Iowa State University in Ames, Iowa. He has worked
for and consulted with leading medical device, pharmaceutical and biotechnology companies ranging in size from start-ups to Fortune 100 companies. He also
works on a regular basis for the U.S. Food and Drug Administration (FDA), Health Canada, the U.S. and European Patent Offices, the Centers for Medicare and
Medicaid Services (CMS) and other regulatory and governmental agencies around the world.
Dr. Drues is an internationally recognized expert and featured keynote speaker on cutting-edge medical technologies and regulatory
affairs. He conducts seminars and short courses for medical device, pharmaceutical and biotechnology companies, the U.S. Food and Drug Administration
(FDA), Health Canada, the U.S. and European Patent Offices, the U.S. Centers for Medicare and Medicare Services (CMS) and other regulatory and governmental
agencies around the world.
Finally, Dr. Drues is an Adjunct Professor of Medicine, Biomedical Engineering & Biotechnology at several universities and medical
schools. He regularly teaches graduate courses in Regulatory Affairs and Clinical Trials, Clinical Trial Design, Medical Device Regulatory Affairs and
Product Development, Combination Products, Pathophysiology, Medical Technology, Translational Medicine and Biotechnology.